切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - ErbB-2 - RET - adrenergic receptor - NADPH Oxidases

12件产品中的 1-10

页面
每页
清除全部
  1. GKT137831
    B4763 GKT137831
     1 Citation
    Target: NADPH Oxidases
    Summary: Nox1/Nox4双重抑制剂
      ≥39.5 mg/mL
      insoluble in H2O
  2. Diphenyleneiodonium chloride
    B6326 Diphenyleneiodonium chloride
    中文名: 二苯基氯化碘盐
    Target: NADPH Oxidases|NOS|GPR3
    Summary: iNOS和eNOS抑制剂,GPR3激动剂
      ≥6.99 mg/mL
      insoluble in H2O
  3. Apocynin
    B3675 Apocynin
    中文名: 罗布麻宁,夹竹桃麻素,香兰基甲基酮
    Target: NADPH Oxidases
    Summary: 选择性NADPH氧化酶抑制剂
      ≥8.25 mg/mL
  4. Epinephrine Bitartrate
    B1358 Epinephrine Bitartrate
    中文名: 酒石酸肾上腺素
    Target: adrenergic receptor
    Summary: 肾上腺素能受体激动剂
      ≥16.66 mg/mL
      ≥22.9 mg/mL
  5. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  6. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  7. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  8. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    中文名: 二苯磺酸拉帕替尼
    Target: EGFR|ErbB-2
    Summary: EGFR / HER2抑制剂
      ≥24.3 mg/mL
      insoluble in H2O
  9. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  10. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O

12件产品中的 1-10

页面
每页